Source / episode info

• **Episode:**435
• **Title:**Divine Intervention Episode 435: Diseases of The Neuromuscular Junction (for Step 1-3)
• **Published:**2023-01-12
• Source:Episode page

One-liner

This episode covers the pathophysiology and clinical presentation of neuromuscular junction disorders, including Myasthenia Gravis (postsynaptic blockade), Lambert-Eaton Myasthenic Syndrome (presynaptic calcium channel defect), Botulism (toxin-mediated ACh release inhibition), and Tetanus (inhibitory neurotransmitter failure).

High-yield summary

• Myasthenia Gravis (MG): Characterized by fluctuating, fatigable weakness (e.g., ptosis, diplopia) due to autoantibodies against the nicotinic acetylcholine receptor (Anti-AChR) or MuSK. Diagnosis relies on a decremental response on RNS and positive serum antibodies.
• Lambert-Eaton Myasthenic Syndrome (LEMS): A presynaptic disorder caused by antibodies targeting voltage-gated calcium channels ({Ca}_V). Key associations include Small Cell Lung Cancer (SCLC) and physical exam findings of hyporeflexia, with an incremental response on RNS.
• Botulism: Caused by the botulinum toxin, which cleaves SNARE proteins (e.g., SNAP-25), preventing acetylcholine release at the NMJ. It presents as a flaccid, descending paralysis and is treated with antitoxin.
• Tetanus vs. Botulism: Tetanus causes spastic paralysis due to impaired inhibitory neurotransmitter release ({GABA}/Glycine); Botulism causes flaccid paralysis due to reduced ACh release.
• MG Crisis Management: Acute exacerbations require high-dose IVIG or Plasma Exchange (PLEX) in addition to standard therapy.
• Diagnostic Testing Pearls: The Tensilon test (edrophonium challenge) and Ice Pack test both temporarily increase acetylcholine levels, improving weakness in MG patients.

Learning objectives

• Differentiate the pathophysiology (postsynaptic vs. presynaptic) and clinical presentation of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
• Interpret electrodiagnostic findings, specifically distinguishing between decremental (MG) and incremental (LEMS/Botulism) responses on repetitive nerve stimulation.
• Identify common sources and mechanisms for botulism and tetanus, including the specific toxins involved.
• Recognize the critical association of LEMS with Small Cell Lung Cancer (SCLC).
• Understand the management principles for acute NMJ crises (IVIG/PLEX for MG; antitoxin for Botulism).